Contact our team

Press Release: Morningside Acquires Life Science Language Services Leader Net-Translators

May 7, 2019

NEW YORK, NY – Morningside Translations, a Top 25 global provider of language services, recently acquired life sciences specialist Net-Translators. Headquartered near Tel Aviv, Israel, Net-Translators provides high-quality translation, localization and multilingual testing services to leading global medical device manufacturers, pharmaceutical companies, life science research organizations, and software developers.

The addition of Net-Translators dramatically expands Morningside’s global life sciences practice and significantly extends its life science reach across Europe, the Middle East, and Asia-Pacific. Morningside is already one of the largest global providers of IP services to the life sciences sector and a major partner to life sciences companies for their regulatory and clinical translation needs.

“We are thrilled to bring Net-Translators into the Morningside fold. This acquisition perfectly fits our DNA as a language service provider focused on regulated industries where quality is paramount,” said Morningside Translations’ co-CEO, Roland Lessard.

As the Tel Aviv branch of Morningside, the Net-Translators team will continue to provide the same exceptional quality and service to clients, while also leveraging Morningside’s broad international presence and top-tier network of linguists and subject matter experts.

The addition of Net-Translators also makes Morningside one of the largest language service employers in Israel, where it has had a robust presence since 2006.

“This is a natural extension for us across EMEA and Asia where our patent and legal work is flourishing,” said co-CEO Tom Klein. “Clients in the U.S. and overseas are always asking us where else we can help them across their broader business portfolios. We’re proud to now offer expanded, specialized capabilities.”

 

About Morningside Translations:

Morningside is the fastest growing major language service provider in North America and one of the largest IP service companies in the world. Specializing in patent, life sciences, and legal services where accuracy and subject matter expertise are paramount, Morningside provides ISO-certified translations into more than 150 languages and offers a suite of technology-enabled localization and IP management solutions. Morningside is the trusted partner to thousands of organizations including Fortune 500 companies, Am Law 200 firms, and international regulatory bodies. Headquartered in New York City, Morningside has offices across the globe in San Francisco, London, Hamburg, and Tel Aviv.